PRESS RELEASE Share Buyback Transaction Details September 11 – September 17, 2025 Alphen aan den Rijn – September 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 78,100 of its own ordinary shares in the period from September 11, 2025, up to and including September 17, 2025, for €8.6 million and at an average share price of €109.74. These repurchases are part of the share buyback program announced ...

Investors looking for signs of a housing market rebound are watching the earnings and commentary from Lennar, one of the nation's largest home builders. ...

LONDON--(BUSINESS WIRE)--FICO (NYSE: FICO) Highlights: Swisscard invests in FICO® Platform's AI-powered decision optimisation capability Partnership will enhance greater flexibility on spending limits while managing risk based on customer behaviours Swisscard has managed onboarding and credit card limit management on FICO® Platform for several years Swisscard, the leading premium credit card provider in Switzerland, has extended its partnership with FICO to optimise its credit limit strategies. ...

Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va. ...

PRESS RELEASE                                         Share Buyback Transaction Details September 11 – September 17, 2025 Alphen aan den Rijn – September 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 78,100 of its own ordinary shares in the period from September 11, 2025, up to and including September 17, 2025, for €8.6 million and at an average share price of €109.74. These repurchases are part ...

Aptevo Therapeutics Inc. APVO jumped 46.10% to $2.06 during after-hours trading on Wednesday following breakthrough clinical results demonstrating its drug’s potential to redefine frontline AML treatment.Check out the current price of APVO stock here.Clinical Trial Delivers Perfect Remission RateThe biotech company from Seattle reported that all patients in Cohort 3 of its Phase 1b/2 RAINIER trial went into complete remission. The trial is testing a treatment called mipletamig, combined with venetoclax and ...

服务定位 - 研究服务专注于为价值投资者寻找亚洲上市股票 这些股票存在价格与内在价值之间的巨大差距[1] - 服务倾向于深度价值资产负债表廉价股 例如以折价购买资产 包括净现金股票 净流动资产股票 低市净率股票 分类加总估值折价股[1] - 同时覆盖宽广护城河股票 例如以折价购买优秀公司的盈利能力的股票 包括"神奇公式"股票 高质量企业 隐形冠军和宽广护城河复合型企业[1] 市场覆盖 - 投资机会主要关注亚洲上市企业 特别是香港市场[1] - 提供一系列观察清单 并在投资研究组内每月更新[1] 作者背景 - 作者负责亚洲价值与护城河股票投资研究组 为价值投资者提供投资理念[1]

Pets At Home on Thursday said its CEO Lyssa McGowan had abruptly left the company after the British retailer issued its second profit warning in two months, sending shares down to their lowest since M... ...

The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the “Greed” zone on Wednesday.U.S. stocks settled mixed on Wednesday, with the Dow Jones index gaining more than 250 points during the session as the Federal Reserve implemented its first interest rate cut of the year.The Federal Reserve delivered a 25-basis-point rate cut and Fed Chair Jerome Powell signaled more easing could be coming — a shift partly driven by a cooling labor market and ...

The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the “Greed” zone on Wednesday.U.S. stocks settled mixed on Wednesday, with the Dow Jones index gaining more than 250 points during the session as the Federal Reserve implemented its first interest rate cut of the year.The Federal Reserve delivered a 25-basis-point rate cut and Fed Chair Jerome Powell signaled more easing could be coming — a shift partly driven by a cooling labor market and ...